Biotech News Portfolio Sarepta Therapeutics

Sarepta: Share Price Explosion after FDA Hammer! And now?

Biotech News | 15.12.2019

There is only one suitable word for yesterdays’ news: sensation! The American healthcare...

Biotech News Portfolio Sarepta Therapeutics

Sarepta Therapeutics: FDA Refuses Marketing Approval for Duchenne Drug Golodirsen

Biotech News | 19.08.2019

The gene therapy powerhouse Sarapta Therapeutics and member of our Model Portfolio has to digest...

Biotech News Portfolio Sarepta Therapeutics

Sarepta after Drop in Share Price: CEO Ingram Now Buys on a Grand Scale

Biotech News | 13.08.2019

After a patient developed a severe side effect in a gene therapy study, the Sarepta share price...

Biotech News Portfolio Sarepta Therapeutics

Sarepta Comments on Incorrect Submission to FDA’s FEARS Adverse Events Reporting System

Biotech News | 08.08.2019

Sarepta Therapeutics, a leading provider of gene therapy for rare diseases and a member of our...